1. Home
  2. WLYB vs LMAT Comparison

WLYB vs LMAT Comparison

Compare WLYB & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLYB
  • LMAT
  • Stock Information
  • Founded
  • WLYB 1807
  • LMAT 1983
  • Country
  • WLYB United States
  • LMAT United States
  • Employees
  • WLYB N/A
  • LMAT N/A
  • Industry
  • WLYB Books
  • LMAT Medical/Dental Instruments
  • Sector
  • WLYB Consumer Discretionary
  • LMAT Health Care
  • Exchange
  • WLYB Nasdaq
  • LMAT Nasdaq
  • Market Cap
  • WLYB 2.3B
  • LMAT 1.9B
  • IPO Year
  • WLYB N/A
  • LMAT 2006
  • Fundamental
  • Price
  • WLYB $44.29
  • LMAT $81.78
  • Analyst Decision
  • WLYB
  • LMAT Buy
  • Analyst Count
  • WLYB 0
  • LMAT 6
  • Target Price
  • WLYB N/A
  • LMAT $100.80
  • AVG Volume (30 Days)
  • WLYB 471.0
  • LMAT 156.0K
  • Earning Date
  • WLYB 06-17-2025
  • LMAT 07-31-2025
  • Dividend Yield
  • WLYB 3.26%
  • LMAT 0.98%
  • EPS Growth
  • WLYB N/A
  • LMAT 30.45
  • EPS
  • WLYB 1.53
  • LMAT 1.97
  • Revenue
  • WLYB $1,677,609,000.00
  • LMAT $226,256,000.00
  • Revenue This Year
  • WLYB N/A
  • LMAT $13.88
  • Revenue Next Year
  • WLYB $1.13
  • LMAT $8.81
  • P/E Ratio
  • WLYB $26.98
  • LMAT $41.48
  • Revenue Growth
  • WLYB N/A
  • LMAT 13.19
  • 52 Week Low
  • WLYB $37.27
  • LMAT $71.42
  • 52 Week High
  • WLYB $52.90
  • LMAT $109.58
  • Technical
  • Relative Strength Index (RSI)
  • WLYB 68.02
  • LMAT 47.11
  • Support Level
  • WLYB $37.27
  • LMAT $80.04
  • Resistance Level
  • WLYB $41.49
  • LMAT $83.15
  • Average True Range (ATR)
  • WLYB 0.64
  • LMAT 1.93
  • MACD
  • WLYB 0.47
  • LMAT -0.01
  • Stochastic Oscillator
  • WLYB 94.74
  • LMAT 42.70

About WLYB John Wiley & Sons Inc.

John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Share on Social Networks: